Menu
Clinical Trials Innovation
A modern clinical trial ecosystem for Europe, at the forefront globally, should consist of two key components:
- Clinical trials that use fit-for-purpose innovation, are centered on patients, caregivers and sites, and support efficient decision-making by regulators, ethics committees, HTA bodies and clinicians, depending on the trial's objective.
- An efficient, risk-based regulatory ecosystem that helps patients and healthcare professionals identify the right trials and provides purposeful transparency.
This track will cover both components, provide a status update and explore where Europe should go next. Sessions will use concrete case studies to identify gaps and opportunities. Through discussions with multiple stakeholders and the audience, the track will explore how to build an attractive European clinical trial ecosystem that supports faster, smarter and more patient-centered trials.
Who Is This Track Designed For?
This track is designed for professionals involved in or interested in clinical trial design and operations, including:
- Regulatory authorities, ethics committees, HTA bodies and payers.
- Commercial and non-commercial sponsors.
- Industry professionals in regulatory policy, regulatory affairs, clinical sciences, clinical operations and biostatistics.
- ROs and service providers.
- Patients, carers and healthcare professional representatives.
- Other stakeholders involved in clinical research.